Motomiya M - Search Results

1

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, et al. Fukuoka M, et al. Among authors: motomiya m. J Clin Oncol. 1992 Jan;10(1):16-20. doi: 10.1200/JCO.1992.10.1.16. J Clin Oncol. 1992. PMID: 1309380 Clinical Trial.

2

[A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].

Negoro S, Fukuoka M, Niitani H, Suzuki A, Nakabayashi T, Kimura M, Motomiya M, Kurita Y, Hasegawa K, Kuriyama T, et al. Negoro S, et al. Among authors: motomiya m. Gan To Kagaku Ryoho. 1991 May;18(6):1013-9. Gan To Kagaku Ryoho. 1991. PMID: 1851408 Clinical Trial. Japanese.

3

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.

Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K, Kuriyama T, et al. Takada M, et al. Among authors: motomiya m. Cancer Chemother Pharmacol. 1992;31(3):182-6. doi: 10.1007/BF00685545. Cancer Chemother Pharmacol. 1992. PMID: 1281446 Clinical Trial.

4

[Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer. KW-2307 Study Group (Lung Cancer Group)].

Furuse K, Kinuwaki E, Motomiya M, Nishiwaki H, Hasegawa K, Kobayashi K, Kurita Y, Ohta K, Fukuoka M, Nakajima S, et al. Furuse K, et al. Among authors: motomiya m. Gan To Kagaku Ryoho. 1994 Sep;21(12):1941-7. Gan To Kagaku Ryoho. 1994. PMID: 8085845 Clinical Trial. Japanese.

5

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group.

Furuse K, Kubota K, Kawahara M, Ogawara M, Kinuwaki E, Motomiya M, Nishiwaki Y, Niitani H, Sakuma A. Furuse K, et al. Among authors: motomiya m. Lung Cancer. 1994 Dec;11(5-6):385-91. doi: 10.1016/0169-5002(94)92167-9. Lung Cancer. 1994. PMID: 7704495 Clinical Trial.

6

Chemotherapy in small cell lung cancer--from view point of dose intensity.

Nakai Y, Koinumaru S, Suzuki S, Saito J, Sugawara S, Numata Y, Sato J, Matsubara N, Motomiya M. Nakai Y, et al. Among authors: motomiya m. Tohoku J Exp Med. 1992 Oct;168(2):427-30. doi: 10.1620/tjem.168.427. Tohoku J Exp Med. 1992. PMID: 1339106 Free article.

7

Changes in serum erythropoietin levels during chemotherapy for lung cancer.

Saijo Y, Nakai Y, Saito J, Sugawara S, Suzuki S, Numata Y, Motomiya M. Saijo Y, et al. Among authors: motomiya m. Chemotherapy. 1992;38(5):281-5. doi: 10.1159/000239014. Chemotherapy. 1992. PMID: 1286570

8

Fatal acute interstitial pneumonia induced by low-dose doxorubicin and vindesine.

Isawa T, Ono R, Motomiya M, Tamahashi N. Isawa T, et al. Among authors: motomiya m. Tohoku J Exp Med. 1989 Jun;158(2):149-54. doi: 10.1620/tjem.158.149. Tohoku J Exp Med. 1989. PMID: 2549658 Free article.

9

[Respiratory infections associated with lung cancer].

Watanabe A, Nakai Y, Saito J, Motomiya M. Watanabe A, et al. Among authors: motomiya m. Gan To Kagaku Ryoho. 1992 Feb;19(2):184-8. Gan To Kagaku Ryoho. 1992. PMID: 1371046 Japanese.

10

Risk of lung cancer by histologic type among smokers in Miyagi Prefecture.

Shimizu H, Hisamichi S, Motomiya M, Oizumi K, Konno K, Hashimoto K, Nakada T. Shimizu H, et al. Among authors: motomiya m. Jpn J Clin Oncol. 1986 Jun;16(2):117-21. doi: 10.1093/oxfordjournals.jjco.a039126. Jpn J Clin Oncol. 1986. PMID: 3016376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters